OMG....You can't be that friggin stupid. I was talking about their pipeline of products. The PR referred to positive results on a pipeline product following a completed Phase II study, and we can't apparently even get the FDA to approve a SPA for ST-246. Give me a break. CMRX's pipeline and trials are for relevant future marketable products, not their anti viral for smallpox. You do realize "Kege" that once the BARDA contract runs out, and barring any further orders from BARDA, or another country, etc....the lights go out here??
Siga is a one product company. Not a good business model if you've every been in business.